An open-label, multicentre clinical trial to determine the levodopa dose-sparing capacity of pramipexole in patients with idiopathic Parkinson's disease

2000 ◽  
Vol 107 (11) ◽  
pp. 1307-1323 ◽  
Author(s):  
M. M. Pinter ◽  
A. W. F. Rutgers ◽  
E. Hebenstreit
Keyword(s):  
Parkinson’S Disease ◽  
Clinical Trial ◽  
Parkinson's Disease ◽  
Idiopathic Parkinson’S Disease ◽  
Open Label ◽  
Levodopa Dose ◽  
Multicentre Clinical Trial ◽  
Idiopathic Parkinson's Disease ◽  
Dose Sparing

Pursuing Multiple Biomarkers for Early Idiopathic Parkinson’s Disease Diagnosis

2021 ◽  
Author(s):  
Yareth Gopar-Cuevas ◽  
Ana P. Duarte-Jurado ◽  
Rosa N. Diaz-Perez ◽  
Odila Saucedo-Cardenas ◽  
Maria J. Loera-Arias ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Disease Diagnosis ◽  
Idiopathic Parkinson’S Disease ◽  
Idiopathic Parkinson's Disease ◽  
Multiple Biomarkers
Sign in / Sign up

Export Citation Format

Share Document